Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
23.44
-0.50 (-2.09%)
At close: Aug 15, 2025, 3:59 PM
23.33
-0.47%
After-hours: Aug 15, 2025, 04:34 PM EDT
Inhibrx Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 186.57M | 216.52M | 152.6M | 196.33M | 226.86M | 252.48M | 277.92M | 337.33M | 192.49M | 234.25M | 273.87M | 146.07M | 176.38M | 143.47M | 131.3M | 112.7M | 125.73M | 107.99M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 6.81M | 6.8M | 6.83M | 6.71M | 6.75M | 4.59M | 3.16M | 3.16M | 3.16M | 3.16M | 3.16M | 3.16M | 3.16M | 1.85M | 1.85M | 245K | 245K | 245K |
Receivables | 967K | 214K | 420K | 1.13M | 1.39M | 3.04M | 778K | 331K | 327K | 304K | 257K | 315K | 284K | 433K | 878K | 503K | 528K | 357K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -331K | 10.18M | -304K | -257K | -315K | n/a | 5.9M | -878K | 5.08M | 4.4M | 4.38M |
Other Current Assets | 6.43M | 1.82M | 816K | 1.84M | 966K | 539K | 16.66M | 25.97M | 324K | 9.52M | 6.63M | 7.68M | 609K | 600K | 7.81M | 747K | 621K | 679K |
Total Current Assets | 193.96M | 223.39M | 160.4M | 207.45M | 242.06M | 274.54M | 295.36M | 363.3M | 203.32M | 243.78M | 280.49M | 153.75M | 181.62M | 150.4M | 139.11M | 119.03M | 131.28M | 113.4M |
Property-Plant & Equipment | 11.35M | 12.45M | 13.54M | 8.4M | 9.62M | 9.45M | 9.37M | 6.27M | 6.68M | 6.78M | 7.22M | 7.93M | 8.42M | 8.93M | 9.49M | 9.9M | 10.36M | 10.86M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 18.15M | 19.25M | 20.37M | 15.12M | 16.36M | 14.04M | 12.54M | 9.44M | 9.85M | 9.94M | 10.38M | 11.1M | 11.59M | 10.78M | 11.34M | 10.15M | 10.61M | 11.1M |
Total Assets | 212.12M | 242.64M | 180.77M | 222.56M | 258.42M | 288.58M | 307.89M | 372.73M | 213.17M | 253.72M | 290.88M | 164.85M | 193.21M | 161.18M | 150.45M | 129.18M | 141.89M | 124.5M |
Account Payables | 8.29M | 8.89M | 9.24M | 12.37M | 13.02M | 12.37M | 10.95M | 7.86M | 9.7M | 10.92M | 8.33M | 8.57M | 9.25M | 7.89M | 9.13M | 12.43M | 9.86M | 14.29M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.87M | 119K | 149K | 166K | 440K | 717K | 1.23M | 2.03M | 2.77M | 3.24M | 4.08M |
Short-Term Debt | 2.17M | n/a | 1.59M | 1.83M | 2.17M | 3.63M | 2.06M | 2.01M | 1.96M | 1.91M | 1.86M | 1.81M | 1.76M | 1.72M | 1.67M | 1.63M | 1.59M | 1.54M |
Other Current Liabilities | 36.77M | 2.72M | 6.13M | 4.63M | 17.18M | 31.91M | 43.3M | 35.77M | 19.55M | 19.67M | 17.22M | 14.61M | 12.47M | 9.27M | 9.62M | 8.33M | 6.98M | 7.94M |
Total Current Liabilities | 38.94M | 43.64M | 40.73M | 44.09M | 39.05M | 71.87M | 56.31M | 35.77M | 31.33M | 32.64M | 27.58M | 25.43M | 24.2M | 20.11M | 22.45M | 25.15M | 21.67M | 27.85M |
Long-Term Debt | 5.34M | 98.65M | n/a | n/a | n/a | 204.58M | 206.97M | 207.37M | 206.65M | 203.26M | 202.07M | 170.82M | 173.93M | 113.73M | 70.47M | 75.54M | 75.57M | 35.75M |
Other Long-Term Liabilities | 99.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.68M | 3.17M | 3.66M | n/a | n/a | 5.14M | 180K | 180K | 180K |
Total Long-Term Liabilities | 104.62M | 104.56M | 6.45M | n/a | n/a | 205.14M | 208.08M | 207.37M | 206.65M | 205.94M | 205.24M | 174.48M | 173.93M | 113.73M | 75.61M | 75.83M | 75.9M | 36.06M |
Total Liabilities | 143.56M | 148.2M | 47.18M | 44.09M | 39.05M | 277.01M | 264.39M | 243.14M | 237.98M | 238.58M | 232.82M | 199.9M | 198.13M | 133.83M | 98.07M | 100.98M | 97.57M | 63.91M |
Total Debt | 7.51M | 106.53M | 8.05M | 1.83M | 2.17M | 210.89M | 208.08M | 207.37M | 208.61M | 203.26M | 202.07M | 172.63M | 175.7M | 115.45M | 70.47M | 77.17M | 77.15M | 37.3M |
Common Stock | 1K | 1K | 1K | 1K | 1K | 5K | 5K | 5K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
Retained Earnings | -178.1M | -149.44M | -106.13M | -58.27M | -14.4M | -692.44M | -613.73M | -520.13M | -468.34M | -421.29M | -372.37M | -331.46M | -296.13M | -258.4M | -227.15M | -205.96M | -185.38M | -164.67M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 68.56M | 94.44M | 133.58M | 178.47M | 219.37M | 11.57M | 43.5M | 129.59M | -24.81M | 15.13M | 58.06M | -35.05M | -4.92M | 27.35M | 52.38M | 28.2M | 44.32M | 60.59M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |